a clinical study to evaluate the efficacy of vidanga-yashti rasayanam on hyperactivity in the management of children afflicted with ADHD

INTERVENTION: CONDITION: Health Condition 1: F901‐ Attention‐deficit hyperactivity disorder, predominantly hyperactive type Health Condition 2: F901‐ Attention‐deficit hyperactivity disorder, predominantly hyperactive type PRIMARY OUTCOME: change in ADHD symptom hyperactivity severity from baseline to the end of the intervention between ; A Children receiving Vidanga Yashti rasayanam along with methylphenidate and ; B Children receiving placebo along with methylphenidate ; Timepoint: 0th 90th day SECONDARY OUTCOME: A To compare the change in the hyperactivity/impulsivity domain score of the Vanderbilt ADHD diagnostic rating scale between the two groups ; B To document and compare the frequency and nature of adverse events occurring in the two study groups ; Timepoint: Day 0 30th 60th 90th INCLUSION CRITERIA: A Children who are diagnosed cases of ADHD & receiving methylphenidate & fulfilling standard diagnostic criteria for ADHD B Parents ready to abide by trial procedure and to give written informed consent C Vaccination completed till age